The airway inflammation model, induced by the administration of bacterial LPS, is a good example of the versatility of Porsolt’s capabilities in determining the anti-inflammatory effects of test substances. Numerous…
Porsolt is attending the European Association for Cancer Research (EACR) meeting this week in Seville, Spain. We are presenting 2 posters describing how preclinical models assist with identifying new therapeutic options…
Porsolt is thrilled to already have our third paper published for this year: “Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T…
Porsolt environment Porsolt is an internationally recognized CRO, known for its innovative and quality approaches in assisting clients at all stages of the preclinical development process. We offer inspiring and…
SAFETY REGULATORY PACKAGE Porsolt’s broad expertise and years of preclinical pharmacology experience makes us the ideal partner to conduct your GLP Safety Pharmacology experiments. Porsolt offers safety studies in both…